The Executive Briefing on OTC Brands

SECONDOPINION

GEO: Are We Optimizing in the Wrong Order?

Hardly any other question is currently occupying marketing teams as intensely as this one: How can we get ChatGPT, Gemini, or the AI assistants at mail-order pharmacies to mention our brand more often? We’re currently going to great lengths to explain to machines what our brand stands for. But is there actually agreement on this among ourselves and our own people?

The market consensus seems unanimous: GEO is the magic word. New analysis tools are being evaluated, prompts monitored, and content curated so that language models will treat a company’s brand more favorably. There’s often an underlying assumption that this is primarily about solving a technical translation problem.



What’s easily overlooked in all this: Of course, data structures, discoverability, and external mentions influence what language models output. But if we take a closer look, the debate reveals a remarkable imbalance. In its current guidelines on generative search, Google continues to recommend clean foundations, technically accessible content, and original, helpful information—and explicitly warns against certain optimization tricks marketed specifically for AI.  And Google is currently the operator that delivers by far the most AI responses through AI Overviews in search results and Gemini prompts.

So while a widely used model operator emphasizes substance, other service providers are already offering the next tactical “secret” shortcut. And even if the GEO measures bear fruit and the brand is mentioned more frequently, it’s worth asking—as always—the follow-up question: Does this effect also lead to more business, value creation, and sustainability? The first AI response is rarely the end of a search: We usually ask two or three times, and the recommendations change along the way. If GEO tools fail to capture this, their validity is, at the very least, debatable.



GEO must therefore be optimized in a highly nuanced and in-depth manner, and optimized figures are often far from being optimal figures. But even if GEO functions flawlessly from a technical standpoint, many questions remain unanswered: What are we actually communicating within this optimized system? What brand identity are we actually presenting there? We’re currently investing considerable energy into teaching machines what our brands stand for, but do all the people who work on and with this brand every day actually share a consistent understanding of it—its core messages and the direction our marketing efforts should take?



Especially in the OTC market, completely different perspectives clash on a daily basis: The brand should be simple, approachable, and distinctive for consumers. At the same time, the organization works with complex scientific data, strict HWG limits, approved indications, and the very specific dynamics of pharmacies, retail, and e-commerce.



Today, we take it for granted that a language model will synthesize a crystal-clear brand narrative from regulatory texts, medical information, PR releases, discount promotions, product pages, and third-party sources. But do we, as an organization, truly succeed in translating this complexity into a shared understanding internally? After all, when Brand Management, Medical Affairs, Trade Marketing, and agencies each conceive and articulate their own version of the brand in their day-to-day work, even the most sophisticated GEO setup conveys exactly that: a non-optimized understanding of the brand. At best, it merely makes our own lack of clarity more quickly machine-readable. So perhaps GEO isn’t the wrong task after all. Perhaps we’re just tackling the tasks in the wrong order.

So what might happen if we viewed AI visibility not just as a technical project, but as an opportunity for honest self-reflection?

"

Let’s just change the order of priorities for a moment:
‍
1. Understanding first, then the tool: Before allocating budgets to ongoing prompt monitoring, it’s worth asking whether there is clarity across all departments and teams about why the brand is a relevant, suitable choice for certain people and usage situations—and what it deliberately does not stand for.

2. Translating complexity internally: A strong OTC brand doesn’t need catchy slogans right off the bat. It needs a shared strategic foundation that brings together medical evidence (Medical), legal frameworks (Regulatory), and consumer benefits (Brand) in such a way that each discipline hits the same core message in its own language. This then makes the central messages clear and immediate all on their own.

3. Substantive Craft Over Short-Term Cosmetic Fixes: When the internal content strategy is sound, the technical groundwork—from cleanly structured product and baseline data to clear advisory content and consistent professional publications—can be completed far more effectively.
‍
We don’t need less GEO. But perhaps we need more clarity about WHAT we’re actually optimizing. A coherent view of our own brand across teams, marketing initiatives, and their messages leads to communication that is clear and easy to grasp. And that’s not only good for machines, but ultimately also for the people who are supposed to understand and want our brand.

The question for the next regular meeting: 



If we were to ask ten colleagues from Brand Management, Medical, Regulatory, Sales, and the agency individually today what defines the core of our brand—would they all describe the same strategic concept? 
And if not, how is AI supposed to figure it out?